Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Hacıbekiroglu · SciRah

Researcher profile · Semantic Scholar

I. Hacıbekiroglu

Share profile

I. Hacıbekiroglu — researcher profile on SciRah

h-index: 14
Works: 120
Citations: 681

Most-cited papers

Frequency of Ras Mutations (Kras, Nras, Hras) in Human Solid Cancer
Hilmi Kodaz, O. Kostek, M. B. Hacıoğlu, B. Erdoğan +5 more
201757 citations Open access
Semantic Scholar
HBV-related acute hepatitis due to immune checkpoint inhibitors in a patient with malignant melanoma.
A. Koksal, Bilal Toka, A. T. Eminler, I. Hacıbekiroglu +2 more
2017Annals of Oncology49 citations Open access
Semantic Scholar
Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study
A. I. Yasin, S. G. Aydin, Bilge Sümbül, L. Koral +25 more
2022Future Oncology31 citations Open access
Semantic Scholar
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
S. Kahraman, E. Erul, Mustafa Seyyar, O. Gumusay +71 more
2023Future Oncology24 citations Open access
Semantic Scholar
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
C. Karaçin, B. Oksuzoglu, A. Demirci, M. Keskinkılıç +82 more
2023BMC Cancer23 citations Open access
Semantic Scholar
Efficacy of metronomic vinorelbine in elderly patients with advanced non-small-cell lung cancer and poor performance status.
C. Bilir, S. Durak, B. Kızılkaya, I. Hacıbekiroglu +2 more
2017Current Oncology23 citations Open access
Semantic Scholar
K-RAS and N-RAS mutations in testicular germ cell tumors.
B. Hacıoglu, Hilmi Kodaz, B. Erdoğan, A. Çinkaya +7 more
2017Bosnian Journal of Basic Medical Sciences23 citations Open access
Semantic Scholar
Relationship between serum osteopontin levels and the severity of COVID-19 infection
C. Varım, T. Demirci, H. Cengiz, I. Hacıbekiroglu +5 more
2020Wiener Klinische Wochenschrift19 citations Open access
Semantic Scholar
Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study
H. Yıldırım, E. Mutlu, E. Chalabiyev, M. Özen +20 more
2022Breast17 citations Open access
Semantic Scholar
Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology
M. Ozcelik, M. Seker, E. Eraslan, S. Koca +15 more
2016Tumor Biology15 citations
Semantic Scholar
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases
S. Kahraman, S. Karakaya, Muhammed Ali Kaplan, S. Goksu +43 more
2024Scientific Reports13 citations Open access
Semantic Scholar
Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World Study
Elif Şenocak Taşçı, A. Mutlu, O. Saylık, Ö. Ölmez +19 more
2024Cancers12 citations Open access
Semantic Scholar
Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer
A. Demirci, C. Bilir, B. Gulbagci, I. Hacıbekiroglu +9 more
2021Scientific Reports12 citations Open access
Semantic Scholar
KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.
Hilmi Kodaz, E. Taştekin, B. Erdoğan, I. Hacıbekiroglu +6 more
2016Balkan Medical Journal12 citations Open access
Semantic Scholar
Major and minor salivary gland cancers: A multicenter retrospective study
M. B. Hacıoğlu, B. Erdoğan, M. Bardakçı, E. Algın +55 more
2023Head and Neck11 citations Open access
Semantic Scholar
Clinical features of the patient with multiple primary tumors: Single center experience
A. Gokyer, O. Kostek, M. B. Hacıoğlu, B. Erdoğan +5 more
2017İstanbul Kuzey Klinikleri11 citations Open access
Semantic Scholar
The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO.
O. Yazıcı, Nuriye Özdemir, A. Duran, S. Menekşe +16 more
2016Future Oncology11 citations
Semantic Scholar
Prognostic Nutritional Index as a Biomarker in Metastatic Hormone‐Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization
M. B. Hacıoğlu, Ahmet Kucukarda, Ivo Gokmen, A. Gurbuz +9 more
2025The Prostate9 citations Open access
Semantic Scholar
CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC
Jay M. Lee, J. Pujol, Jun Zhang, O. Leonov +15 more
2025JTO Clinical and Research Reports9 citations Open access
Semantic Scholar
Unknown primary adenocarcinomas: a single-center experience.
S. Uzunoğlu, B. Erdoğan, Hilmi Kodaz, A. Çinkaya +6 more
2016Bosnian Journal of Basic Medical Sciences9 citations Open access
Semantic Scholar
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)
C. Erol, A. Sakin, Tuğba Başoğlu, Ercan Özden +45 more
2022Turkish Journal of Medical Sciences8 citations Open access
Semantic Scholar
Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less
Ersin Özaslan, H. Karaca, S. Koca, A. Sevınc +15 more
2017Anti-Cancer Drugs7 citations Open access
Semantic Scholar
Prognostic Role of Inflammatory and Nutritional Indices in NSCLC Patients Treated with Immune Checkpoint Inhibitors: Retrospective, Multicenter, Turkish Oncology Group Study of Overall and Elderly Populations
O. Alan, T. Telli, Sinem Akbaş, S. Işık +18 more
2025Medicina6 citations Open access
Semantic Scholar
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
S. Kahraman, E. Erul, O. Gumusay, D. Guven +66 more
2025Clinical Breast Cancer6 citations Open access
Semantic Scholar
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study
I. Cil, Ahmet Kucukarda, M. Atcı, Şaban Seçmeler +16 more
2021Tumori6 citations
Semantic Scholar
Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)
A. Inal, Hilmi Kodaz, H. Odabaş, A. Duran +25 more
2018Journal of Cancer Research and Therapeutics6 citations Open access
Semantic Scholar
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey
A. Akyıldız, D. Guven, A. Ozluk, Rashad Ismayilov +30 more
2023Medicine5 citations Open access
Semantic Scholar
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
C. Karaçin, B. Oksuzoglu, A. Demirci, M. Keskinkılıç +82 more
2023BMC Cancer5 citations Open access
Semantic Scholar
Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group
C. Erol, Mehmet Ali Nahit Sendur, I. Bilgetekin, D. B. Garbioğlu +47 more
2022Journal of Cancer Research and Therapeutics5 citations Open access
Semantic Scholar
Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma.
O. Kostek, Erdem Yilmaz, M. B. Hacıoğlu, B. Erdoğan +6 more
2018Journal of B.U.ON. : official journal of the Balkan Union of Oncology5 citations
Semantic Scholar
A rare cause in etiology of left atrial mass: metastatic testicular germ cell tumor
S. Huseyın, V. Yüksel, Ahmet Okyay, I. Hacıbekiroglu +5 more
2016Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery5 citations Open access
Semantic Scholar
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab.
A. Güren, N. Demircan, Özge Gümüşay, E. Şimşek +34 more
2026Immunotherapy4 citations
Semantic Scholar
Gustave Roussy immune score as an independent prognostic factor for treatment response and survival in advanced renal cell carcinoma treated with nivolumab in second-line and beyond
B. Erdoğan, İ. Gökmen, Çağnur Elpen Kodaz, A. Küçükarda +8 more
2025Frontiers in Oncology4 citations Open access
Semantic Scholar
Clinical Outcomes of CDK4/6 Inhibitor Therapy in HR+/HER2− Metastatic Breast Cancer: A Multicenter Comparison of HER2-Low and HER2-Zero Subgroups
Erkan Ozcan, Ivo Gokmen, Fahri Akgul, F. Kahvecioglu +4 more
2025The Breast Journal4 citations Open access
Semantic Scholar
Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience
N. Demirci, E. Çavdar, N. Ozdemir, S. Yuksel +8 more
2024Medicina4 citations Open access
Semantic Scholar
Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer.
E. Şeber, Y. Iriagac, E. Çavdar, Kubilay Karaboyun +13 more
2024Journal of the College of Physicians and Surgeons--Pakistan : JCPSP4 citations Open access
Semantic Scholar
PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score
I. Bayoğlu, Javid Huseynov, Alper Topal, Nadiye Sever +13 more
2023Journal of Clinical Medicine4 citations Open access
Semantic Scholar
Psoas muscle mass, nutritional status, inflammation, and their relationship with prognosis in patients with pancreatic adenocarcinoma.
I. Yıldırım, T. Kaya, K. Işsever, A. C. Genç +3 more
2021Nutrición Hospitalaria4 citations Open access
Semantic Scholar
Efficacy of convalescent plasma according to blood groups in COVID-19 patients
T. Hacıbekiroğlu, Y. Kalpakçı, A. Genç, I. Hacıbekiroglu +5 more
2020Turkish Journal of Medical Sciences4 citations Open access
Semantic Scholar
Microbiota and Cancer
A. Genç, I. Hacıbekiroglu
20174 citations
Semantic Scholar
Assessment of Prognostic Factors in Epithelial Ovarian Cancer
Y. Onal, O. Kostek, Muhammet Bekir Hacioðlu, Bülent Erdoðan +5 more
20174 citations Open access
Semantic Scholar
Post progression survival analysis of metastatic gastric and gastroesophageal junction cancer patients after second-line treatment.
E. Turkmen, B. Erdoğan, Hilmi Kodaz, I. Hacıbekiroglu +4 more
2016Acta gastro-enterologica Belgica4 citations
Semantic Scholar
Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
S. Tunbekici, Gökhan Şahin, Sercan Ön, Ahmet Oruç +72 more
2025International Journal of Cancer3 citations
Semantic Scholar
The efficacy of a computer alert programme for increasing HBV screening rates before starting immunosuppressive therapy.
A. Koksal, Bilal Toka, A. T. Eminler, I. Hacıbekiroglu +4 more
2019Acta gastro-enterologica Belgica3 citations
Semantic Scholar
Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treated advanced melanoma patients
N. Karadurmuş, Mehmet Ali Nahit Sendur, B. Karaca, O. F. Olmez +15 more
2018Journal of Oncological Sciences3 citations Open access
Semantic Scholar
Second-line nab-paclitaxel and gemcitabine for advanced pancreatic cancer following FOLFIRINOX: outcomes and insights.
Aysegul Merc Cetınkaya, A. Tatlı, Sabin Goktas Aydın, S. Kılıçkap +20 more
2026American Journal of Cancer Research2 citations
Semantic Scholar
Real‐world comparison of cabozantinib and sunitinib in advanced non‐clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group
Gökhan Şahin, E. Tüzün, H. G. Güzel, Murad Guliyev +57 more
2025International Journal of Cancer2 citations
Semantic Scholar
Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach
H. Bozcuk, L. Sert, M. A. Kaplan, A. Tatlı +22 more
2025Cancers2 citations Open access
Semantic Scholar
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing
O. Kostek, A. Demirel, M. B. Hacıoğlu, D. Taştekin +43 more
2024Journal of chemotherapy2 citations
Semantic Scholar
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience
N. Majidova, M. Sarı, F. Kahvecioglu, Erkan Ozcan +20 more
2024Oncology Research and Treatment2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. Çiçin×15
Invite
I. Çiçin — researcher profile on SciRah
O. Kostek×14
Invite
O. Kostek — researcher profile on SciRah
Hilmi Kodaz×10
Invite
Hilmi Kodaz — researcher profile on SciRah
I. Bayoğlu×10
Invite
I. Bayoğlu — researcher profile on SciRah

×9

Invite

S. Kahraman — researcher profile on SciRah

Invite

T. Şakalar — researcher profile on SciRah

Invite

S. Menekşe — researcher profile on SciRah

Invite

M. Şendur — researcher profile on SciRah

M. B. Hacıoğlu×8

Invite

M. B. Hacıoğlu — researcher profile on SciRah

S. Uzunoğlu×8

Invite

S. Uzunoğlu — researcher profile on SciRah

Invite

B. Gulbagci — researcher profile on SciRah

Invite

A. Çelebi — researcher profile on SciRah